{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:43:41Z","timestamp":1792691021411,"version":"4.5.0"},"reference-count":48,"publisher":"MyJove Corporation","issue":"89","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/51643","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T20:00:01Z","timestamp":1405022401000},"source":"Crossref","is-referenced-by-count":7,"title":["Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation"],"prefix":"10.3791","author":[{"given":"Insaf","family":"Salem Fourati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Julie","family":"Grenier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lyse","family":"Jolette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Merindol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ovetchkine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Soudeyns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","type":"journal-article","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","unstructured":"Ballen, K. K. et al. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 122(4), 491-498, doi:10.1182\/blood-2013-02-453175 (2013).","journal-title":"Blood"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbmt.2008.05.006","type":"journal-article","article-title":"Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation","volume":"14","author":"Vandenbosch","year":"2008","unstructured":"Vandenbosch, K. et al. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol. Blood Marrow Transplant. 14(8), 867-871, doi:10.1016\/j.bbmt.2008.05.006 (2008).","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbmt.2005.02.004","type":"journal-article","article-title":"Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source","volume":"11","author":"Barker","year":"2005","unstructured":"Barker, J. N. et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol. Blood Marrow Transplant. 11(5), 362-370, doi:10.1016\/j.bbmt.2005.02.004 (2005).","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.1201759","type":"journal-article","article-title":"Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation","volume":"189","author":"Merindol","year":"2012","unstructured":"Merindol, N. et al. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation. J. Immunol. 189(10), 5016-5028, doi:10.4049\/jimmunol.1201759 (2012).","journal-title":"J. Immunol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","type":"journal-article","article-title":"Varicella in children with cancer: Seventy-seven cases","volume":"56","author":"Feldman","year":"1975","unstructured":"Feldman, S. et al. Varicella in children with cancer: Seventy-seven cases. Pediatrics. 56(3), 388-397 (1975).","journal-title":"Pediatrics"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1083-8791(00)70004-8","type":"journal-article","article-title":"Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients","volume":"6","author":"Arvin","year":"2000","unstructured":"Arvin, A. M. Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol. Blood Marrow Transplant. 6(3), 219-230, doi:10.1016\/S1083-8791(00)70004-8 (2000).","journal-title":"Biol. Blood Marrow Transplant"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-11-31","type":"journal-article","article-title":"Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis","volume":"11","author":"Wiegering","year":"2011","unstructured":"Wiegering, V. et al. Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis. BMC Pediatr. 11, 31, doi:10.1186\/1471-2431-11-31 (2011).","journal-title":"BMC Pediatr"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","type":"journal-article","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","unstructured":"Boeckh, M. et al. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. Blood. 107(5), 1800-1805, doi:10.1182\/blood-2005-09-3624 (2006).","journal-title":"Blood"},{"issue":"3","key":"ref9","first-page":"60","type":"journal-article","article-title":"Prevention of VZV infection in immunosuppressed patients using antiviral agents","volume":"13","author":"Boeckh","year":"2006","unstructured":"Boeckh, M. Prevention of VZV infection in immunosuppressed patients using antiviral agents. Herpes. 13(3), 60-65 (2006).","journal-title":"Herpes"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","type":"journal-article","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","unstructured":"Tomblyn, M. et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol. Blood Marrow Transplant. 15(10), 1143-1238, doi:10.1016\/j.bbmt.2009.06.019 (2009).","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"2","key":"ref11","first-page":"185","type":"journal-article","article-title":"Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro","volume":"1","author":"Ljungman","year":"1986","unstructured":"Ljungman, P. et al. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplant. 1(2), 185-192 (1986).","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1989.88","type":"journal-article","article-title":"The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"59","author":"Selby","year":"1989","unstructured":"Selby, P. J. et al. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Br. J. Cancer. 59(3), 434-438 (1989).","journal-title":"Br. J. Cancer"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2008.09.004","type":"journal-article","article-title":"Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation","volume":"14","author":"Distler","year":"2008","unstructured":"Distler, E. et al. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation. Biol. Blood Marrow Transplant. 14(12), 1417-1424, doi:10.1016\/j.bbmt.2008.09.004 (2008).","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","type":"journal-article","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","unstructured":"Levin, M. J. et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J. Infect. Dis. 188(9), 1336-1344, doi:10.1086\/379048 (2003).","journal-title":"J. Infect. Dis"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/eji.200737648","type":"journal-article","article-title":"Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus","volume":"37","author":"Jones","year":"2007","unstructured":"Jones, L. et al. Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus. Eur. J. Immunol. 37(12), 3393-3403, doi:10.1002\/eji.200737648 (2007).","journal-title":"Eur. J. Immunol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0022-1759(88)90079-8","type":"journal-article","article-title":"Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells","volume":"110","author":"Czerkinsky","year":"1988","unstructured":"Czerkinsky, C. et al. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods. 110(1), 29-36, doi:10.1016\/0022-1759(88)90079-8 (1988).","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(89)90281-0","type":"journal-article","article-title":"The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays","volume":"120","author":"Hutchings","year":"1989","unstructured":"Hutchings, P. R. et al. The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays. J. Immunol. Methods. 120(1), 1-8, doi:10.1016\/0022-1759(89)90281-0 (1989).","journal-title":"J. Immunol. Methods"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1089\/aid.2010.0340","type":"journal-article","article-title":"Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults","volume":"27","author":"De Castro","year":"2011","unstructured":"De Castro, N. et al. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults. AIDS Res. Hum. Retroviruses. 27(10), 1089-1097, doi:10.1089\/aid.2010.0340 (2011).","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"19","key":"ref19","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1128\/JVI.00564-06","type":"journal-article","article-title":"Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection","volume":"80","author":"Jones","year":"2006","unstructured":"Jones, L. et al. Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection. J. Virol. 80(19), 9772-9778, doi:10.1128\/JVI.00564-06 (2006).","journal-title":"J. Virol"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003789","type":"journal-article","article-title":"Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka","volume":"3","author":"Malavige","year":"2008","unstructured":"Malavige, G. N. et al. Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka. PLoS One. 3(11), e3789, doi:10.1371\/journal.pone.0003789 (2008).","journal-title":"PLoS One"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/592219","type":"journal-article","article-title":"Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay","volume":"198","author":"Sadaoka","year":"2008","unstructured":"Sadaoka, K. et al. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay. J. Infect. Dis. 198(9), 1327-1333, doi:10.1086\/592219 (2008).","journal-title":"J. Infect. Dis"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CDLI.8.5.871-879.2001","type":"journal-article","article-title":"Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus","volume":"8","author":"Smith","year":"2001","unstructured":"Smith, J.G. et al. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin. Diagn. Lab. Immunol. 8(5), 871-879, doi:10.1128\/CDLI.8.5.871-879.2001 (2001).","journal-title":"Clin. Diagn. Lab. Immunol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.coviro.2013.04.004","type":"journal-article","article-title":"T-cell immunity to human alphaherpesviruses","volume":"3","author":"Ouwendijk","year":"2013","unstructured":"Ouwendijk, W. J. et al. T-cell immunity to human alphaherpesviruses. Curr. Opin. Virol. 3(4), 452-460, doi:10.1016\/j.coviro.2013.04.004 (2013).","journal-title":"Curr. Opin. Virol"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1172\/JCI4314","type":"journal-article","article-title":"Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi","volume":"102","author":"Rowland-Jones","year":"1998","unstructured":"Rowland-Jones, S. L. et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 102(9), 1758-1765, doi:10.1172\/JCI4314 (1998).","journal-title":"J. Clin. Invest"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/339338","type":"journal-article","article-title":"Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection","volume":"185","author":"Alter","year":"2002","unstructured":"Alter, G. et al. Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. J. Infect. Dis. 185(6): 755-765, doi:10.1086\/339338 (2002).","journal-title":"J. Infect. Dis"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","type":"journal-article","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","unstructured":"Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191(9), 1499-1512, doi:10.1084\/jem.191.9.1499 (2000).","journal-title":"J. Exp. Med"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/infdis\/jit267","type":"journal-article","article-title":"A heterologous prime\/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus","volume":"208","author":"Fournillier","year":"2013","unstructured":"Fournillier, A. et al. A heterologous prime\/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus. J. Infect. Dis. 208(6), 1008-1019, doi:10.1093\/infdis\/jit267 (2013).","journal-title":"J. Infect. Dis"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","type":"journal-article","article-title":"Interferon-\u03b3 ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial","volume":"187","author":"Adetifa","year":"2013","unstructured":"Adetifa, I. M. et al. Interferon-\u03b3 ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. Am. J. Respir. Crit. Care Med. 187(4), 439-445, doi:10.1164\/rccm.201208-1352OC (2013).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/bmb\/ldp039","type":"journal-article","article-title":"A 100 year update on diagnosis of tuberculosis infection","volume":"93","author":"Lalvani","year":"2010","unstructured":"Lalvani, A., & Pareek, M. A 100 year update on diagnosis of tuberculosis infection. Br. Med. Bull. 93, 69-84, doi:10.1093\/bmb\/ldp039 (2010).","journal-title":"Br. Med. Bull"},{"key":"ref30","type":"journal-article","article-title":"A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older","volume":"178 Suppl. 1","author":"Berger","year":"1998","unstructured":"Berger, R. et al. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older. J. Infect. Dis. 178 Suppl. 1, S99-103, doi:10.1086\/514265 (1998).","journal-title":"J. Infect. Dis"},{"issue":"16","key":"ref31","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0264-410X(99)00510-1","type":"journal-article","article-title":"Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial","volume":"18","author":"Trannoy","year":"2000","unstructured":"Trannoy, E. et al. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine. 18(16), 1700-1706, doi:10.1016\/S0264-410X(99)00510-1 (2000).","journal-title":"Vaccine"},{"issue":"2","key":"ref32","first-page":"181","type":"journal-article","article-title":"Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs","volume":"14","author":"Brunner","year":"1968","unstructured":"Brunner, K.T. et al. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 14(2), 181-196 (1968).","journal-title":"Immunology"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.158.2.571","type":"journal-article","article-title":"Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations","volume":"158","author":"Moretta","year":"1983","unstructured":"Moretta, A. et al. Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. J. Exp. Med. 158(2), 571-585, doi:10.1084\/jem.158.2.571 (1983).","journal-title":"J. Exp. Med"},{"issue":"1-2","key":"ref34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-1759(93)90158-4","type":"journal-article","article-title":"Detection of intracellular cytokines by flow cytometry","volume":"159","author":"Jung","year":"1993","unstructured":"Jung, T. et al. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods. 159(1-2), 197-207, doi:10.1016\/0022-1759(93)90158-4 (1993).","journal-title":"J. Immunol. Methods"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-6-13","type":"journal-article","article-title":"Standardization of cytokine flow cytometry assays","volume":"6","author":"Maecker","year":"2005","unstructured":"Maecker, H.T. et al. Standardization of cytokine flow cytometry assays. BMC Immunol. 6, 13 (2005).","journal-title":"BMC Immunol"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/cyto.a.20602","type":"journal-article","article-title":"Standardization and optimization of multiparameter intracellular cytokine staining","volume":"73","author":"Nomura","year":"2008","unstructured":"Nomura, L. et al. Standardization and optimization of multiparameter intracellular cytokine staining. Cytometry A. 73(11), 984-991, doi:10.1002\/cyto.a.20602 (2008).","journal-title":"Cytometry A"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1046-2023(03)00124-5","type":"journal-article","article-title":"Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining","volume":"31","author":"Letsch","year":"2003","unstructured":"Letsch, A., & Scheibenbogen, C. Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining. Methods. 31(2), 143-149, doi:10.1016\/S1046-2023(03)00124-5 (2003).","journal-title":"Methods"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4049\/jimmunol.0902613","type":"journal-article","article-title":"Umbilical cord blood T cells respond against the Melan-A\/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells","volume":"185","author":"Merindol","year":"2010","unstructured":"Merindol, N., et al. Umbilical cord blood T cells respond against the Melan-A\/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells. J. Immunol. 185(2), 856-866, doi:10.4049\/jimmunol.0902613 (2010).","journal-title":"J. Immunol"},{"issue":"5284","key":"ref39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","type":"journal-article","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","unstructured":"Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274(5284), 94-96, doi:10.1126\/science.274.5284.94 (1996).","journal-title":"Science"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.4049\/jimmunol.175.10.6334","type":"journal-article","article-title":"Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining","volume":"175","author":"Scriba","year":"2005","unstructured":"Scriba, T. J. et al. Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining. J. Immunol. 175(10), 6334-6343 (2005).","journal-title":"J. Immunol"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.4049\/jimmunol.1101734","type":"journal-article","article-title":"Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRs","volume":"187","author":"Stone","year":"2011","unstructured":"Stone, J. D. et al. Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRs. J. Immunol. 187(12), 6281-6290, doi:10.4049\/jimmunol.1101734 (2011).","journal-title":"J. Immunol"},{"issue":"18","key":"ref42","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1073\/pnas.94.18.9848","type":"journal-article","article-title":"Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection","volume":"94","author":"Pantaleo","year":"1997","unstructured":"Pantaleo, G. et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc. Natl Acad. Sci. USA. 94(18), 9848-9853, doi:10.1073\/pnas.94.18.9848 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","type":"journal-article","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12(6), 492-499, doi :10.1038\/ni.2035 (2011).","journal-title":"Nat. Immunol"},{"issue":"1-2","key":"ref44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2006.11.010","type":"journal-article","article-title":"A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses","volume":"320","author":"Boulet","year":"2007","unstructured":"Boulet, S. et al. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J. Immunol. Methods. 320(1-2), 18-29, doi:10.1016\/j.jim.2006.11.010 (2007).","journal-title":"J. Immunol. Methods"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-61779-325-7_6","type":"journal-article","article-title":"Dual- and triple-color fluorospot","volume":"792","author":"Ahlborg","year":"2012","unstructured":"Ahlborg, N., & Axelsson, B. Dual- and triple-color fluorospot. Methods Mol. Biol. 792, 77-85, doi:10.1007\/978-1-61779-325-7_6 (2012).","journal-title":"Methods Mol. Biol"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.20062363","type":"journal-article","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"Precopio","year":"2007","unstructured":"Precopio, M. L. et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204(6), 405-1416, doi:10.1084\/jem.20062363 (2007).","journal-title":"J. Exp. Med"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.4049\/jimmunol.159.6.2802","type":"journal-article","article-title":"Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes","volume":"159","author":"Sadzot-Delvaux","year":"1997","unstructured":"Sadzot-Delvaux, C. et al. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J. Immunol. 159(6), 2802-2806 (1997).","journal-title":"J. Immunol"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.bjc.6605542","type":"journal-article","article-title":"IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies","volume":"102","author":"Malavige","year":"2010","unstructured":"Malavige, G. N. et al. IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies. Br. J. Cancer. 102(4), 727-730, doi:10.1038\/sj.bjc.6605542 (2010).","journal-title":"Br. J. Cancer"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jove.com\/video\/51643\/development-an-ifn-elispot-assay-to-assess-varicella-zoster-virus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:27:41Z","timestamp":1792690061000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/51643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":48,"journal-issue":{"issue":"89","published-online":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3791\/51643","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,9]]}}}